| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 531* | 2021 |
| Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma V Mazzaferro, C Sposito, J Zhou, AD Pinna, L De Carlis, J Fan, M Cescon, ... Gastroenterology 154 (1), 128-139, 2018 | 505 | 2018 |
| Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence G Ercolani, GL Grazi, M Ravaioli, M Del Gaudio, A Gardini, M Cescon, ... Annals of surgery 237 (4), 536-543, 2003 | 458 | 2003 |
| Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma A Cucchetti, F Piscaglia, M Cescon, A Colecchia, G Ercolani, L Bolondi, ... Journal of hepatology 59 (2), 300-307, 2013 | 428 | 2013 |
| Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ... American Journal of Transplantation 8 (12), 2547-2557, 2008 | 428 | 2008 |
| Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value GL Grazi, G Ercolani, F Pierangeli, M Del Gaudio, M Cescon, A Cavallari, ... Annals of surgery 234 (1), 71-78, 2001 | 403 | 2001 |
| Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G La Barba, ... Liver Transplantation 12 (6), 966-971, 2006 | 330 | 2006 |
| Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years M Cescon, G Vetrone, GL Grazi, G Ramacciato, G Ercolani, M Ravaioli, ... Annals of surgery 249 (6), 995-1002, 2009 | 281 | 2009 |
| Is portal hypertension a contraindication to hepatic resection? A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G Ramacciato, ... Annals of surgery 250 (6), 922-928, 2009 | 270 | 2009 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 230 | 2021 |
| In hepatocellular carcinoma miR‐519d is up‐regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 F Fornari, M Milazzo, P Chieco, M Negrini, E Marasco, G Capranico, ... The Journal of pathology 227 (3), 275-285, 2012 | 229 | 2012 |
| Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population A Cucchetti, F Piscaglia, E Caturelli, L Benvegnù, M Vivarelli, G Ercolani, ... Annals of surgical oncology 16, 413-422, 2009 | 222 | 2009 |
| Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study A Cucchetti, F Piscaglia, ADE Grigioni, M Ravaioli, M Cescon, M Zanello, ... Journal of hepatology 52 (6), 880-888, 2010 | 196 | 2010 |
| Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma M Cescon, A Colecchia, A Cucchetti, E Peri, L Montrone, G Ercolani, ... Annals of surgery 256 (5), 706-713, 2012 | 188 | 2012 |
| The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy G Ercolani, GL Grazi, M Ravaioli, WF Grigioni, M Cescon, A Gardini, ... Annals of Surgery 239 (2), 202-209, 2004 | 181 | 2004 |
| Prognostic factors for hepatocellular carcinoma recurrence A Colecchia, R Schiumerini, A Cucchetti, M Cescon, M Taddia, G Marasco, ... World journal of gastroenterology: WJG 20 (20), 5935, 2014 | 173 | 2014 |
| Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival G Ercolani, G Vetrone, GL Grazi, O Aramaki, M Cescon, M Ravaioli, ... Annals of surgery 252 (1), 107-114, 2010 | 171 | 2010 |
| Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate M Cescon, A Cucchetti, M Ravaioli, AD Pinna Journal of hepatology 58 (3), 609-618, 2013 | 170 | 2013 |
| Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience M Del Gaudio, G Ercolani, M Ravaioli, M Cescon, A Lauro, M Vivarelli, ... American journal of transplantation 8 (6), 1177-1185, 2008 | 166 | 2008 |
| In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis F Fornari, D Pollutri, C Patrizi, T La Bella, S Marinelli, A Casadei Gardini, ... Clinical cancer research 23 (14), 3953-3965, 2017 | 161 | 2017 |
